Dmitry Balyasny’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Dmitry Balyasny’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-360,599	Closed	-$573K	–	3267
2024 Q1	$573K	Buy	+360,599	New	+$535K	﹤0.01%	2000
2023 Q1	–	Sell	-15,600	Closed	-$78.3K	–	3284
2022 Q4	$78.3K	Buy	+15,600	New	+$97.8K	﹤0.01%	2281

Dmitry Balyasny's NGM Position: Q2 2024 in Review

Dmitry Balyasny sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 360,599 shares — an estimated $573K sold.

Dmitry Balyasny first reported a position in NGM in Q4 2022 and held it in 2 quarters. The position peaked at $573K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Dmitry Balyasny reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Dmitry Balyasny sold 360,599 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $573K.
Dmitry Balyasny first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Dmitry Balyasny's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $573K in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.